Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDC42EP4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBL5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLC12A9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PSEN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TIMM17A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SRGN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HEXIM1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
APOBEC3F - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
STAMBP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SUPT7L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC100129924 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
KMO - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OPTN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DHX57 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PIGP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LINC00623 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYP27B1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GTF2A2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TBPL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
REEP5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on